Many in vitro studies have shown that AR signaling consistently inhibits the basal and estrogen-induced proliferation and survival of MCF-7, T47D and ZR-75-1 cell lines (classical models of luminal BC) [115,116,119]. Here, AR is linked to breast cancer.